TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Hew Proposes New Rules For Pregnant Women, Fetuses, Prisoners In Research August 30, 1974